...the burden of mental illness and addictions in Ontario is more than 1.5 times that of all cancers and more than seven times that of all infectious diseases.
Atlanta, GA (PRWEB) October 19, 2012
MissionIR would like to highlight GreeneStone Healthcare Corporation. The publicly traded company operates medical clinics in Ontario, Canada. GreeneStone offers various medical services, including addiction treatment, endoscopy, minor cosmetic procedures, and executive health care services. It operates four medical clinics consisting of three in Toronto and a facility in Muskoka, Ontario.
In the company’s news yesterday, GreeneStone Healthcare announced that it will begin the application process to list on the NYSE-Amex exchange. Following the company’s recent performance, GreeneStone has met, or nearly met, the listing requirements for the NYSE-Amex under its Standard 3 definitions.
The NYSE-Amex listing is believed to best serve GreeneStone’s needs as management pursues capital to support the recently announced ‘build and buy’ expansion strategy. This strategy is designed to take advantage of the numerous opportunities within the underserviced mental healthcare sector in Canada and the US. The expansion strategy’s first projected milestone is to reach the 300 bed level in its in-patient addiction treatment business in the next twenty-four months.
The huge demand for mental healthcare services identified by the company early on has been confirmed by a recently released report. The report was released last week by the Institute for Clinical Evaluation Sciences (ICES) and Public Health Ontario. The report demonstrates that “the burden of mental illness and addictions in Ontario is more than 1.5 times that of all cancers and more than seven times that of all infectious diseases.” The report goes on to say “five conditions have the highest impact on the life and health of Ontarians: depression, bipolar disorder, alcohol use disorders, social phobia and schizophrenia.”
Research has shown that mental disorders and addictions are very prevalent. In fact, one in five Canadians are estimated to experience a mental disorder at least once a year. Mental conditions and addictions cost Canada an estimated forty to fifty billion dollars annually. Last week’s study confirms that the burden of mental disorders and addictions is very high and outstrips the burden of many physical illnesses.
“This report does not surprise me, the numbers are staggering,” commented Shawn Leon CEO of GreeneStone. “The awareness of mental health is growing and we are set to carve out a niche in this sector.”
ICES is an independent, non-profit organization that produces knowledge to enhance the effectiveness of healthcare for Ontarians. To access the 6-page summary and full report, visit the ICES Web site at http://www.ices.on.ca/webpage.cfm?site_id=1&org_id=31&morg_id=0&gsec_id=0&item_id=7718
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
To sign up for The MissionIR Report, please visit http://MissionIR.com
To connect with MissionIR via Facebook, please visit http://Facebook.com/MissionIR
To connect with MissionIR via Twitter, please visit http://Twitter.com/MissionIR
Please read FULL disclaimer on the MissionIR website: http://Disclaimer.MissionIR.com
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.